Skip to main content
. 2013 Jul 23;6(4):308–316. doi: 10.1002/dta.1507

Table 2.

Concentration distribution in post-mortem (PM) femoral blood and proportion of fatal poisonings for 129 drugs

Drug Cases LOQ PM mean PM median PM upper percentiles mg/L Therapeutic range in plasmaa Proportion of fatal poisonings PM blood/therapeutic plasma concentration relationshipb
N mg/L mg/L mg/L 90th 95th 97.5th mg/L %
1 Acebutolol 85 0.25 11 0.84 25 86 100 0.2-2 20 1
2 Alprazolam 940 0.02 0.09 0.05 0.20 0.30 0.40 0.005-0.05 13 1
3 Aminophenazone, 4-methyl 330 2/3c 25 15 58 82 103 10d 1 1
4 Amiodarone 125 0.4 3.4 1.8 7.7 11 15 1-2 1 1
5 Amitriptyline 1589 0.1 1.5 0.40 2.9 5.5 8.8 0.05-0.3 27 1.3
6 Amlodipine 313 0.006 0.10 0.07 0.20 0.26 0.34 0.003-0.015 3 4.5
7 Amphetamine 565 0.04 0.91 0.28 2.1 3.7 6.2 0.02-0.1 12 2.8
8 Atenolol 415 0.2 1.3 0.64 2.6 4.6 6.9 0.1-1 6 1
9 Betaxolol 124 0.003 0.22 0.10 0.31 0.41 0.43 0.005-0.05 2 1.9
10 Biperiden 30 0.1 0.20 0.10 0.30 0.30 0.66 0.05-0.1 0 1
11 Bisoprolol 3633 0.01 0.12 0.05 0.17 0.26 0.43 0.01-0.1 1 1
12 Bupivacaine 49 0.2 1.2 0.40 1.6 3.0 4.3 0.5-1.5 0 0.80
13 Buprenorphine 671 0.0002 0.0033 0.0012 0.0058 0.0093 0.022 0.0005-0.005 45 1
14 Caffeine 22125 1/3c 4.0 3.0 7.5 10 13 4-10 0 0.75
15 Carbamazepine 1482 1/0.3c 7.9 6.2 13 19 27 2-8 2 1
16 Carvedilol 134 0.003 0.05 0.02 0.08 0.13 0.43 appr. 0.02-0.15 0 1
17 Celiprolol 105 0.03 2.1 0.28 2.7 5.2 6.9 0.05-0.5 6 1
18 Cetirizine 99 0.005 0.41 0.10 0.92 1.9 2.9 appr. 0.02-0.3 0 1
19 Chlordiazepoxide 1714 0.2 1.4 0.70 3.5 5.2 7.6 0.4-3 1 1
20 Chloroquine 47 0.2 12 1.3 43 62 69 0.02-0.5 15 2.6
21 Chlorpromazine 246 0.05 1.0 0.30 2.2 3.9 6.5 0.03-0.1 11 3.0
22 Chlorprothixene 519 0.1 1.7 0.30 3.0 5.2 9.0 0.02-0.3 18 1
23 Citalopram 3542 0.1 0.97 0.40 1.4 2.4 5.3 0.05- 0.11 4 3.6
24 Clonazepam 77 0.01 0.06 0.03 0.10 0.20 0.31 0.02-0.08 5 1
25 Clozapine 445 0.1 2.5 1.1 4.4 8.9 17 0.35-0.6 13 1.8
26 Codeine 1903 0.02 0.72 0.16 1.8 3.2 5.1 0.03-0.25 23 1
27 Cyclizine 48 0.005 1.1 0.30 1.2 2.1 6.0 0.1-0.25 2 1.2
28 Desmethyldiazepam 9459 0.02 0.21 0.10 0.50 0.70 1.0 0.2 -0.8 0 0.13
29 Dextromethorphan 54 0.1 0.69 0.40 1.6 2.2 2.8 0.01-0.04 15 10
30 Dextropropoxyphene 249 0.1 6.5 2.6 12 17 38 0.05-0.3 59 8.7
31 Diazepam 7404 0.02 0.17 0.09 0.4 0.6 0.8 0.1-2 0 0.90
32 Diclofenac 20 0.5 2.5 1.3 6.6 7.1 8.5 0.5-3 0 1
33 Diltiazem 315 0.1 2.5 0.30 1.8 7.9 22 0.03-0.13 9 2.3
34 Diphenhydramine 57 0.005 0.35 0.20 0.80 0.90 0.96 0.05-0.1 0 2.0
35 Dixyrazine 52 0.003 0.70 0.10 1.8 3.9 6.4 appr. 0.3 42 0.33
36 Donepezil 102 0.003 0.23 0.20 0.41 0.49 0.60 appr. 0.03-0.075 0 2.7
37 Doxepin 678 0.05 2.4 0.60 6.7 12 15 0.01-0.2 42 3.0
38 Duloxetine 109 0.01 0.37 0.14 0.64 1.1 2.4 0.03-0.12 8 1.2
39 Ephedrine 156 0.04 0.66 0.21 1.1 1.6 3.1 0.02-0.2 2 1.1
40 Ethylmorphine 71 0.02 0.44 0.10 1.3 2.6 2.8 0.3-0.6 6 0.33
41 Etoricoxib 55 0.5 3.5 1.2 4.2 5.5 6.8 1.3-3.6 0 0.92
42 Fentanyl 419 0.0001 0.012 0.0058 0.023 0.040 0.061 0.001-0.01e 12 1
43 Flecainide 101 0.2 4.7 1.9 9.8 19 23 0.4-0.8 18 2.4
44 Fluconazole 275 0.1 6.3 3.8 15 23 28 appr. 1-5 0 1
45 Fluoxetine 649 0.2 0.80 0.50 1.6 2.5 3.6 0.12-0.5 3 1
46 Fluvoxamine 79 0.03 2.6 0.70 7.7 11 21 0.06-0.23 13 3.0
47 Furosemide 294 0.1 2.6 0.90 5.5 9.5 16.7 2-5 0 0.45
48 Gabapentine 135 1 29 11 60 103 157 appr. 0.5-6 8 1.8
49 Galantamine 44 0.01 0.21 0.11 0.38 0.46 1.1 appr. 0.03-0.06 0 1.8
50 Glimepiride 177 0.01 0.31 0.03 0.26 0.61 1.2 0.09-0.5 1 0.33
51 Haloperidol 94 0.003 0.05 0.01 0.06 0.29 0.40 0.005-0.017 5 1
52 Hydroxycarbamazepine 475 5/3c 27 22 52 66 92 10-35 0 1
53 Hydroxychloroquine 165 1 14 10 30 35 52 -0.1 14 100
54 Hydroxyzine 159 0.2 0.80 0.30 1.6 2.8 5.3 0.05-0.1 16 3.0
55 Ibuprofen 379 10 26 19 45 62 89 15-30 0 1
56 Indomethacin 9 0.5 1.2 1.1 1.6 1.7 1.8 0.3-1 0 1.1
57 Ketamine 118 0.1 1.1 0.50 2.2 4.1 6.3 1-6 1 0.50
58 Ketoprofen 80 0.3 3.2 1.3 5.7 7.6 16 appr. 3.7 0 0.34
59 Labetalol 62 0.01 0.20 0.09 0.30 0.45 1.2 0.03-0.18 0 1
60 Lamotrigine 338 1/0.5c 5.7 3.8 12 18 25 3-14 4 1
61 Levetiracetam 105 3 26 15 55 76 94 10-40 1 1
62 Levomepromazine 1602 0.1 0.99 0.40 1.9 3.2 5.0 0.005-0.025 23 16
63 Lidocaine 2391 0.1 0.81 0.40 1.8 2.8 4.1 1.5-5 0 0.27
64 Lithium 165 0.5 3.2 2.0 6.3 9.4 13 4-8 7 0.50
65 Lorazepam 802 0.01 0.06 0.03 0.10 0.20 0.30 0.08-0.25 0 0.38
66 MDMA 57 0.04 0.76 0.30 2.1 3.5 4.0 0.1-0.35 0 1
67 Melperone 161 0.05 1.5 0.40 3.3 9 14 0.03-0.1 32 4.0
68 Meprobamate 20 10 74 28 121 159 434 5-10 5 2.8
69 Mesoridazine 85 0.2 0.75 0.50 1.3 1.6 2.7 0.15-1 0 1
70 Metformin 1376 1 15 6 36 69 110 0.1-1 6 5.5
71 Methadone 207 0.05 0.59 0.40 1.3 1.8 2.2 0.1-0.5 43 1
72 Methamphetamine 51 0.04 1.7 0.18 1.2 2.2 25 -0.1 10 1.8
73 Metoclopramide 681 0.05 0.21 0.10 0.4 0.6 0.7 0.05-0.15 0 1
74 Metoprolol 2078 0.05 0.96 0.20 1.1 2.0 5.0 0.035-0.5 2 1
75 Mianserin 387 0.05 0.37 0.20 0.70 0.97 1.9 0.015-0.07 7 2.9
76 Midazolam 172 0.02 0.14 0.07 0.40 0.54 0.84 0.04-0.1 2 1
77 Mirtazapine 2179 0.05 0.49 0.20 0.80 1.7 2.9 0.03-0.08 6 2.5
78 Moclobemide 135 0.1 15 1.9 41 61 120 0.3-1.0 13 1.9
79 Morphine 1094 0.02 0.20 0.07 0.37 0.67 1.1 0.01-0.1 4 1
80 Naproxen 202 10 43 33 78 100 120 20-50 1 1
81 Nifedipine 43 0.02 0.31 0.10 0.46 0.69 0.89 0.025-0.15 2 1
82 Nitrazepam 37 0.05 0.13 0.06 0.30 0.42 0.50 0.03-0.1 11 1
83 Olanzapine 1127 0.05 0.41 0.20 0.60 1.1 2.2 0.02-0.08 5 2.5
84 Orphenadrine 284 0.1 0.95 0.30 1.6 3.5 6.2 0.1-0.2 4 1.5
85 Oxazepam 6277 0.02 0.28 0.07 0.7 1.2 1.9 0.2-1.5 0 0.35
86 Oxcarbazepine 71 0.3 1.2 0.60 2.4 4.0 5.3 0.4-2 1 1
87 Oxycodone 1259 0.02 0.34 0.10 0.50 0.84 1.7 0.005-0.1 8 1
88 Paracetamol 3100 5/10c 32 15 62 110 190 10-25 2 1
89 Paroxetine 326 0.004 0.81 0.24 1.4 2.2 3.8 < 0.01-0.05 18 4.7
90 Perphenazine 283 0.005 0.08 0.01 0.08 0.18 0.36 0.001-0.02 2 1
91 Pethidine 46 0.1 0.50 0.30 0.90 1.1 1.9 0.1-0.8 2 1
92 Phenazepam 20 0.03 0.13 0.09 0.20 0.22 0.41 0.02-0.04 0 2.1
93 Phenobarbital 7 10 29 30 44 49 52 10-30 0 1
94 Phenylpropanolamine 65 0.04 0.49 0.14 0.98 1.4 2.5 0.1-0.5 0 1
95 Phenytoin 37 10 14 13 22 25 31 5-15 0 1
96 Pholcodine 73 0.02 0.37 0.19 0.80 1.0 1.5 appr. 0.07-0.2 3 1
97 Pregabalin 380 0.2 15 8.0 35 52 96 2-5 12 1.6
98 Promazine 339 0.1 4.5 1.2 11 19 26 0.01-0.05 42 24
99 Propofol 299 0.1/0.5c 2.5 1.3 5.0 8.2 11 appr. 2-8 1 0.65
100 Propranolol 1078 0.02 1.8 0.13 5.4 11 16 0.02-0.3 15 1
101 Pseudoephedrine 127 0.04 0.81 0.24 1.5 2.4 3.6 0.5-0.8 0 0.48
102 Quetiapine 505 0.2 0.62 0.90 13 30 44 0.1-0.5 18 1.8
103 Quinine 322 0.2 3.5 1.0 4.7 23 34 1-7 3 1
104 Risperidone 622 0.002 0.014 0.004 0.029 0.044 0.086 appr. 0.006 1 1
105 Rivastigmine 56 0.003 0.03 0.01 0.05 0.08 0.12 0.008-0.02 2 1
106 Ropivacaine 44 0.1 0.90 0.70 2.1 2.4 2.9 -1.5f 0 1
107 Salicylic acid 733 5/3c 48 11 83 150 430 20-200 2 0.55
108 Sertraline 445 0.1 0.55 0.30 1.0 1.7 2.3 0.05-0.25 5 1.2
109 Sildenafil 44 0.03 0.41 0.10 0.44 0.53 4.3 appr. 0.05-0.5 2 1
110 Sitagliptin 68 0.01 0.61 0.36 1.3 2.1 2.8 0.05-0.38 0 1
111 Sotalol 120 0.25 2.8 2.0 5.5 8.1 11 0.5-3 1 1
112 Sulpiride 95 0.02 4.2 1.1 7.5 23 33 0.05-0.4 18 2.8
113 Temazepam 6283 0.02 0.34 0.09 0.90 1.4 2.3 0.02-0.15 2 1
114 Tetrahydrocannabinol 347 0.001 0.005 0.002 0.008 0.013 0.024 0.005-0.01 0 0.40
115 Theophylline 52 10 25 15 34 88 107 8-15 4 1
116 Thioridazine 283 0.1 1.3 0.70 2.9 4.3 5.3 0.1-2 6 1
117 Tizanidine 107 0.003 0.12 0.02 0.27 0.48 0.90 appr. 0.015 7 1
118 Topiramate 56 1/3c 16 8.8 21 27 40 2-10 2 1
119 Tramadol 1581 0.1 3.1 0.90 6.50 13 21 0.1-1 18 1
120 Trazodone 58 0.2 2.1 0.40 4.7 9.6 20 0.7-1 7 0.57
121 Trimethoprim 419 1 3.7 2.3 6.7 9.3 13 1.5-2.5 0 1
122 Trimipramine 248 0.1 1.1 0.60 2.4 3.4 4.7 0.01-0.3 19 2.0
123 Valproic acid 956 1/3c 51 28 75 110 230 40-100 2 0.70
124 Venlafaxine 824 0.1 3.7 0.60 5.7 17 33 0.1-0.4 17 1.5
125 Verapamil 174 0.1 2.1 0.35 5.9 9.7 13 0.02-0.25 16 1.4
126 Warfarin 425 0.5 0.81 0.70 1.1 1.6 2.4 1-3 0 0.70
127 Zolpidem 287 0.1 0.59 0.30 1.4 2.0 2.9 0.08-0.15 19 2.0
128 Zopiclone 2577 0.02 0.34 0.10 0.8 1.5 2.4 0.01-0.05 13 2.0
129 Zuclopenthixol 171 0.005 0.10 0.05 0.20 0.30 0.58 0.004-0.05 3 1
a

Information derived from Schulz et al.1

b

Median PM concentration within the established therapeutic range in plasma = 1

Median PM concentration below the therapeutic range divided by the lower limit of the therapeutic range (<1)

Median PM concentration above the therapeutic range divided by the upper limit of the therapeutic range (>1)

c

Data combined from two successive methods; validation parameters presented in order of appearance

d

For parent drug metamizole

e

Information derived from Winek et al.32

f

Information derived from Dollery33